Veeva Systems Inc. (0LO3.L)
USD 217.0
(-1.92%)
USD 217.0
(-1.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 429.33 Million USD | -5.38% |
| 2023 | 488.21 Million USD | -8.39% |
| 2022 | 505.49 Million USD | 30.86% |
| 2021 | 407.24 Million USD | 29.68% |
| 2020 | 286.21 Million USD | 32.54% |
| 2019 | 236.93 Million USD | 43.54% |
| 2018 | 179.47 Million USD | 35.53% |
| 2017 | 121.79 Million USD | 39.91% |
| 2016 | 87.05 Million USD | 17.81% |
| 2015 | 73.89 Million USD | 77.15% |
| 2014 | 41.71 Million USD | 35.34% |
| 2013 | 30.82 Million USD | 337.5% |
| 2012 | 7.04 Million USD | 32.67% |
| 2011 | 5.31 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 144.97 Million USD | 5.93% |
| 2024 Q1 | 69.07 Million USD | -40.76% |
| 2024 Q2 | 112.13 Million USD | 62.33% |
| 2024 FY | - USD | -4.45% |
| 2024 Q3 | 136.85 Million USD | 22.04% |
| 2023 Q3 | 128.56 Million USD | 18.69% |
| 2023 Q1 | 134.73 Million USD | 6.29% |
| 2023 FY | - USD | -8.39% |
| 2023 Q2 | 108.32 Million USD | -19.6% |
| 2023 Q4 | 116.6 Million USD | -9.3% |
| 2022 Q4 | 126.75 Million USD | -9.2% |
| 2022 Q2 | 131.5 Million USD | -2.64% |
| 2022 Q1 | 135.07 Million USD | 27.94% |
| 2022 FY | - USD | 30.86% |
| 2022 Q3 | 139.6 Million USD | 6.16% |
| 2021 Q4 | 105.57 Million USD | -2.99% |
| 2021 FY | - USD | 29.68% |
| 2021 Q1 | 95.44 Million USD | 33.34% |
| 2021 Q3 | 108.83 Million USD | 11.74% |
| 2021 Q2 | 97.39 Million USD | 2.05% |
| 2020 Q1 | 76.6 Million USD | 15.04% |
| 2020 Q3 | 86.44 Million USD | 8.85% |
| 2020 FY | - USD | 32.54% |
| 2020 Q4 | 71.57 Million USD | -17.2% |
| 2020 Q2 | 79.41 Million USD | 3.67% |
| 2019 FY | - USD | 43.54% |
| 2019 Q4 | 66.59 Million USD | 0.17% |
| 2019 Q3 | 66.47 Million USD | 18.04% |
| 2019 Q2 | 56.31 Million USD | 18.43% |
| 2019 Q1 | 47.55 Million USD | 23.37% |
| 2018 FY | - USD | 35.53% |
| 2018 Q3 | 45.26 Million USD | 11.86% |
| 2018 Q4 | 38.54 Million USD | -14.86% |
| 2018 Q1 | 40.78 Million USD | 13.27% |
| 2018 Q2 | 40.46 Million USD | -0.78% |
| 2017 Q1 | 21.21 Million USD | 12.67% |
| 2017 Q4 | 36.01 Million USD | -3.4% |
| 2017 FY | - USD | 39.91% |
| 2017 Q3 | 37.27 Million USD | 36.59% |
| 2017 Q2 | 27.29 Million USD | 28.67% |
| 2016 Q2 | 23.69 Million USD | 7.96% |
| 2016 Q1 | 21.94 Million USD | 1.29% |
| 2016 FY | - USD | 17.81% |
| 2016 Q4 | 18.82 Million USD | -16.63% |
| 2016 Q3 | 22.58 Million USD | -4.71% |
| 2015 FY | - USD | 77.15% |
| 2015 Q4 | 21.66 Million USD | 3.37% |
| 2015 Q3 | 20.96 Million USD | 17.93% |
| 2015 Q2 | 17.77 Million USD | 31.8% |
| 2015 Q1 | 13.48 Million USD | 10.86% |
| 2014 Q2 | 10.34 Million USD | 22.62% |
| 2014 FY | - USD | 35.34% |
| 2014 Q3 | 10.75 Million USD | 3.96% |
| 2014 Q4 | 12.16 Million USD | 13.08% |
| 2014 Q1 | 8.44 Million USD | -12.22% |
| 2013 Q4 | 9.61 Million USD | 7.33% |
| 2013 Q3 | 8.95 Million USD | 0.0% |
| 2013 FY | - USD | 337.5% |
| 2012 FY | - USD | 32.67% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 517.052% |
| Accuray Incorporated | 9 Million USD | -4665.612% |
| Align Technology, Inc. | 799.03 Million USD | 46.269% |
| Elevance Health Inc. | 10.49 Billion USD | 95.907% |
| AxoGen, Inc. | -13.32 Million USD | 3321.294% |
| Boston Scientific Corporation | 3.61 Billion USD | 88.117% |
| CVS Health Corporation | 18.17 Billion USD | 97.638% |
| Cardinal Health, Inc. | 1.97 Billion USD | 78.295% |
| Centene Corporation | -463 Million USD | 192.729% |
| DaVita Inc. | 2.34 Billion USD | 81.703% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 96.625% |
| Hologic, Inc. | 1.29 Billion USD | 66.877% |
| Humana Inc. | -561 Million USD | 176.53% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 64.741% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | 68.183% |
| Masimo Corporation | 236.7 Million USD | -81.383% |
| McKesson Corporation | 4.66 Billion USD | 90.801% |
| Patterson Companies, Inc. | 374.75 Million USD | -14.564% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 75.212% |
| ResMed Inc. | 1.6 Billion USD | 73.172% |
| Henry Schein, Inc. | 943 Million USD | 54.471% |
| Teladoc Health, Inc. | 153.99 Million USD | -178.794% |
| Universal Health Services, Inc. | 1.74 Billion USD | 75.374% |
| Baxter International Inc. | 2.77 Billion USD | 84.534% |
| Becton, Dickinson and Company | 4.27 Billion USD | 89.957% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 82.067% |
| Danaher Corporation | 7.49 Billion USD | 94.275% |
| Stryker Corporation | 5.16 Billion USD | 91.68% |
| Medtronic plc | 9.05 Billion USD | 95.259% |